Our annual World TB Day symposium, held on March 24th, 2025, brought together a vibrant mix of national and international voices, researchers, policymakers, and individuals with lived experience of tuberculosis (TB). Hosted as a hybrid event by the London School of Hygiene & Tropical Medicine (LSHTM) and UCL, the day was filled with insightful discussions, cutting-edge research presentations, and a powerful sense of community aimed at tackling the global challenge of TB.

A Gathering of Diverse Perspectives

A key strength of this year’s symposium was the convergence of UK-based and international perspectives. In a time where global health funding faces uncertainty, the event highlighted a strong recognition that collaboration is crucial. We can support and learn from each other, strengthening our collective efforts against TB.

This spirit of inclusivity shone through, particularly with the powerful contributions from TB survivors. Hearing directly from Mariama Barrow and Amy McConville, representing experiences from both high-burden settings and the UK, provided invaluable context and grounded the day’s discussions. Mariama’s use of photography to share her treatment journey was particularly moving, and helped people to see how the reality of treatment affects the person receiving it.

Key Themes and Discussions

The symposium’s structure was thoughtfully designed to cover critical areas in TB research and policy:

• Life After TB: Placing the “Post-TB – Beyond the cure” session early in the day emphasized the often-overlooked long-term health issues faced by survivors. Presentations covered post-TB lung disease, innovative therapies, and the experiences of paediatric survivors, reminding us that the journey doesn’t necessarily end when treatment does.
• UK’s Role in TB Policy: An honest and open session explored the UK’s position in national and international TB policy. Speakers from UK government bodies, the Global Fund, and advocacy groups discussed TB rates, policy options, and the importance of sustained commitment and funding.
• Debating Future Treatments: This lively debate, “This house believes that Pan-TB regimens are dead in the water,” delved into the complexities and potential consequences of seeking simpler, programmatic solutions for TB treatment.
• Spotlight on Early Career Researchers: The ECR “Turbo Talks” were a highlight, showcasing the incredible breadth and quality of research happening at LSHTM and UCL. The fast-paced, two-minute format, enabled by technology allowing presenters from around the globe, was both engaging and inclusive. Congratulations to all of the presenters – everyone was a winner!
• Asymptomatic TB: This topical session addressed the latest in definitions, screening, diagnosis, biomarkers, and treatment for early and asymptomatic TB, highlighting the important contributions of LSHTM and UCL researchers in this area.

And then, as always, really great to hook up with UCSF, not least at a time when things are uncertain for global research and implementation. With changes occurring in funding and the delivery of care, it feels particularly important now to connect with groups as part of the global community doing important and high quality TB research.

Looking Forward

The symposium fostered a strong sense of community and shared purpose. From the insightful survivor testimonies to the dynamic ECR presentations and high-level policy discussions, the event underscored the power of collaboration and inclusivity. While challenges remain, particularly around funding and the complexities of TB treatment and long-term care, the collective energy and commitment demonstrated give reason for optimism.

---

📽️ A video of the symposium can be seen here

---

 

UK Academics and Professionals to End TB (UKAPTB) are a grassroots network of healthcare professionals and researchers interested in working together to push for changes in policy and funding that will bolster efforts to eliminate TB.

We held our first in-person meeting on Friday 26^th January 2024 hosted by the Centre for Tuberculosis Research at the Liverpool School of Tropical Medicine bringing together people working in a variety of contexts with representation from NHS England, the UK Health Security Agency (UKHSA), local public health, affected communities, civil society, parliamentarians, university-based researchers,  health workers and funders.

The meeting was held at Spaces at The Spine, a building with a distinctive façade a symbolic reference to nature, located in Liverpool’s Knowledge Quarter just a short walk from the national train station. We were blessed with a crisp bright morning providing phenomenal views over the city from the 13^th floor – a wonderful space to catch up with old friends and meet new faces.

The day was split into three main points of discussion: strengthening partnerships to accelerate the UK’s efforts to end TB; how to get back on track towards eliminating TB in the UK and; how do we ensure TB is on the antimicrobial resistance agenda in the United Nations High-Level Meeting this year. The day was designed to facilitate discussion through short presentations, panel discussions which later opened for audience interventions and plenty of time and space for conversations to continue over coffee and Scouse stew.

“despite the UK being a leader in TB research, we do not implement in the UK all the innovations we have contributed evidence for“

Some of the key messages that came out of the day were about building strong, equitable partnerships – be that in UK research collaborations with the Global South and explicit practices of decentring colonial power which came out in the session showcasing TB research around the UK, or partnerships with affected communities, policy makers, civil society, academics and healthcare workers. However, it was noted that despite the UK being a leader in TB research, we do not implement in the UK all the innovations we have contributed evidence for: Video Observed Therapy is not accessible across the country, rifapentine-isoniazid fixed dose combination is not routinely accessible and people with multi-drug resistant TB struggle to access the latest shorter all-oral regimens due to difficulties procuring key medicines.

Other challenges experienced by healthcare workers in the UK included structural conditions that both challenged people with TB and the services designed to care for them. Most people diagnosed with TB in the UK were originally born in high burden TB countries. The government’s hostile environment policy agenda makes TB prevention, care and surveillance incredibly difficult for some of the people most at-risk of TB. In addition, the cost-of-living crisis negatively impacts the social determinants of TB including access to good quality housing, nutrition and employment. TB teams must address these complex issues if they are to successfully support people through diagnosis and treatment completion. This takes huge resource which is frequently not provided by budget holders as they grapple different priorities and an NHS in crisis.

“We need to embed TB prevention and care into other relevant agendas”

As countries move towards TB elimination, the need to move away from single disease policies and vertical funding will become ever more pressing. Health system strengthening is therefore key to building resilience into end TB strategies. In the UK one example of ensuring access to specialist advice for complex patients in a low incidence setting was to set up through a virtual multidisciplinary team meeting with an experienced clinician. Getting TB on the agenda has long been an issue in terms of funding. Academics and healthcare professionals have a credible and powerful voice but banging the TB drum and publication of peer reviewed journal articles are often not the best way to make ourselves heard. We need to embed TB prevention and care into other relevant agendas including for example, universal health coverage, pandemic prevention, preparedness and response, anti-microbial resistance, the climate emergency. Finally, we must be less squeamish at engaging politicians and policymakers to do this.

“there was a buzz of energy that lasted throughout the day”

There are no short-cuts for this kind of advocacy work – relationships take hard graft and personal connections and must be an exchange of information and not a one-way street. Policymakers need to be able to reach out to the right people and be given information in ways that are understandable, relevant and timely and we need to support that. Building partnerships, strengthening our networks and producing fruitful collaborations to end TB was the aim of the day. There are multiple groups working on TB who are UK-based – whether their work is targeted across the four nations or globally – each with their own agendas and skill set. The aim of this event was to join things up; showcase and share the variety of work streams in action; connecting disciplines and geographies to generate new ways of seeing and doing. Despite the early start for many, and a vast amount of information-sharing, there was a buzz of energy that lasted throughout the day and into our journeys home. We need to keep building this momentum through the upcoming World TB Day and beyond – only together will we succeed in creating a TB-free world.

---

UKAPTB: https://www.ukaptb.org
UKAPTB news: https://www.ukaptb.org/news-and-events
Contact UKAPTB: ukaptb@gmail.com

Jess is lead of the TB service at North Middlesex University Hospital in London. She is co-chair of the UKAPTB and advocacy lead for the European network TBnet. Jess is a qualitative researcher interested in access to health care and the structural conditions that shape these experiences. jessica.potter3@nhs.net

Images courtesy of KC (view of Liverpool) and Alejandra Cardona-Mayorga, Liverpool School of Tropical Medicine (UKAPTB meeting session)

I met Sreyashi Basu in mid-January this year. She’d dropped in to say hello to Prof Tim McHugh, who’d been a project supervisor during her UCL BSc course, which had finished the previous summer. 

I was amazed at how she had spent the six months after graduating setting up a TB initiative in Kolkata from scratch, coming up with an original idea, and working with laboratory scientists, local artists, charities, and schools to engage children and communities with information about TB. She’d also designed materials, produced videos and set up a website.

I was keen to know more, and over email, Sreyashi told me about herself, and about her project, Joi Hok! (which means “Let victory be yours!”).

(more…)

 

Professor Neil Stoker attended two events to mark World TB Day 2019; firstly, a reception at the UK Parliament and secondly, our World TB Day Symposium. Neil shares his reflections here.

---

The political and the personal

“28th of January. We have to strike a pretty miserable deal with our drug resistant TB patients. Their only, though by no means guaranteed, chance of cure is to take up to eight unpalatable and side effect-prone drugs for at least two years. Often after only a couple of weeks of treatment, patients will develop anticipatory gagging and vomiting just on seeing the tablets, or rashes so itchy they excoriate their arms and legs.

“Pyrazinamide can make their joints so painful, it’s difficult to stand. Clofazimine causes their skin to become discoloured like an overcooked fake tan – so that one remaining neighbour who didn’t already know that that patient had TB will now guess. Cycloserine can precipitate neurological and psychiatric symptoms, including psychosis and suicidal ideation. 

(more…)